Glenmark Pharma’s Q4: Net Profit Misses Estimates, Announces Dividend and Major Leadership Transition

Glenmark Pharmaceuticals Ltd has released its March quarter results, unveiling a mixed financial performance alongside a significant change in its top management. The company’s net profit fell sharply below analyst expectations, even as it maintained steady sales and announced a final dividend.

 

Key Highlights:

 

Q4 Financials: Glenmark Pharma reported consolidated net sales of ₹32.2 billion for the March quarter, reflecting resilience in its core operations despite sector headwinds. However, consolidated net profit came in at just ₹46.5 million, a dramatic miss compared to the IBES estimate of ₹3.16 billion. The profit slump was attributed to exceptional items and higher tax expenses during the quarter.

 

Dividend Announcement: The Board has recommended a final dividend of ₹2.5 per share for FY25, continuing its track record of shareholder payouts. The ex-dividend date is set for September 13, 2025, offering some relief to investors amid the earnings disappointment.

 

Leadership Reshuffle: In a major development, V.S. Mani, Executive Director and Global CFO, will step down effective May 26, 2025, after an eight-year tenure. Mani cited his decision to retire after crossing the age of 60, and will remain with the company for a smooth transition. Anurag Mantri, a seasoned chartered accountant with over 30 years’ experience—including key roles at Jindal Stainless, L&T, HCL, and Cairn Energy—has been appointed as President and will assume the role of Executive Director and Global CFO upon board approval.

 

Strategic Outlook: The leadership transition is seen as part of Glenmark’s broader efforts to strengthen governance and operational efficiency. The company expressed confidence in Mantri’s ability to drive future growth and navigate evolving market dynamics.

 

Glenmark’s Q4 results and executive changes mark a pivotal moment for the company as it balances operational challenges with a renewed focus on leadership and governance.

 

Sources: Moneycontrol, CNBC TV18, eHealth, India Infoline, Angel One